Publikationsansicht

P18-12 LB. Phase I clinical trial with a new recombinant MVA-BN®-multiantigen vaccine: high responder rate and considerable breadth of immunological response (2009)

Abstract
No abstract available.

Details der Publikation
Download http://www.retrovirology.com/content/6/S3/P411
Herausgeber BioMed Central Ltd.
Archiv BioMed Central (United Kingdom)
Typ Poster presentation
Sprache Englisch